Highlights
NASDAQ: CTIC       Cti Biopharm Corp
Last Price Today's Change   Day's Range   Trading Volume
1.50   -0.03 (1.96%)  1.43 - 1.93  4,179,200

Overview

 
Avg Volume (4 weeks):771,657
4 Weeks Range:0.70 - 1.93
4 Weeks Price Volatility (%):
65.04%
52 Weeks Range:0.60 - 1.93
52 Weeks Price Volatility (%):
67.67%
Average Price Target: 3.00
Price Target Upside/Downside: +1.50

Headlines



No recent Headlines for this stock.


Business Background

CTI Biopharma Corp is a biopharmaceutical company focused on the development and commercialization of less toxic, more effective cancer therapies. The company's therapeutic area is blood-related cancers. One of the company's products, Pixantrone (PIXUVRI), received conditional marketing approval in the EU in 2012 to treat refractory aggressive B-cell non-Hodgkin lymphoma. Another product is Pacritinib, an oral tyrosine kinase inhibitor to treat mutations such as Janus associated kinase 2 (JAK2) and FMS-like tyrosine kinase 3 (FLT3).

  Be the first to like this.
 


 

3995  4101  641  182 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 EEM 44.42-0.02 
 SPY 317.32+0.19 
 AMD 41.15-1.44 
 VXX 15.53-0.67 
 DHR 148.52-2.78 
 CHK 0.789+0.006 
 FXI 42.60-0.18 
 GE 11.34-0.10 
 BAC 34.44-0.24 
Partners & Brokers